Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds Vivashaematology-oncology-and-transfusion

Paeds Vivas · haematology-oncology-and-transfusion

Aplastic anaemia and bone-marrow failure: Viva

Branching clinical structured oral on aplastic anaemia and inherited bone marrow failure in children, covering the Camitta severity criteria, the immune-mediated pathophysiology, the diepoxybutane test for Fanconi anaemia, the treatment fork of transplant versus immunosuppression, the horse versus rabbit antithymocyte globulin choice, and the eltrombopag and the RACE trial, appraising the Camitta, Frickhofen, Scheinberg, and Peffault de Latour evidence.

branching clinical structured oral4 min readVerification in progress

Target exams

RACP DWERACP DCEMRCPCH Clinical
On this page
Study tools

Target exams

RACP DWERACP DCEMRCPCH Clinical
Prompt
A nine-year-old boy presents with three weeks of bruising and tiredness. His full blood count shows pancytopenia with a neutrophil count of 0.3 times ten to the nine per litre, platelets of 12 times ten to the nine per litre, and a reticulocyte count of 10 times ten to the nine per litre. The bone marrow trephine shows a cellularity of 15 percent with no blasts and a normal karyotype. The examiner asks you to grade the severity, explain the pathophysiology, exclude the inherited syndromes, and outline the definitive treatment with its trial evidence.

This is a presentation of severe aplastic anaemia in a nine-year-old boy, meeting the Camitta criteria. The structured oral runs from the severity grading through the pathophysiology, the exclusion of the inherited syndromes, the treatment fork, and the trial evidence, and it ends with the long term counselling. [1]

Opening: grade the severity

Examiner. This boy has pancytopenia and a hypocellular marrow. How do you grade the severity, and what does the grade mean for the treatment? [1]

Candidate. The boy meets the Camitta criteria for severe aplastic anaemia, which is a marrow cellularity under 25 percent together with at least two of three peripheral blood thresholds. He has a cellularity of 15 percent, which meets the marrow criterion, and he meets all three blood thresholds: the neutrophils of 0.3 times ten to the nine per litre are under 0.5, the platelets of 12 times ten to the nine per litre are under 20, and the reticulocytes of 10 times ten to the nine per litre are under 60. The grade is severe, and it is close to very severe, which is the neutrophils under 0.2 times ten to the nine per litre. The grade matters because the severe and the very severe disease are treated aggressively with the transplant or the immunosuppression, while the non-severe disease is often managed supportively. [1]

Paediatrics Fellowship Pro

Continue reading

You have read the opening of this viva. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References5ShowHide
  1. [1]Camitta BM, Thomas ED, Nathan DG, et al Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood, 1976.PMID 779871
  2. [3]Frickhofen N, Kaltwasser JP, Schrezenmeier H, et al Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group. N Engl J Med, 1991.PMID 2017225
  3. [4]Scheinberg P, Nunez O, Weinstein B, et al Horse versus rabbit antithymocyte globulin in acquired aplastic anemia. N Engl J Med, 2011.PMID 21812672
  4. [7]Peffault de Latour R, Kulasekararaj A, Iacobelli S, et al Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia. N Engl J Med, 2022.PMID 34986284
  5. [9]Auerbach AD Fanconi anemia and its diagnosis. Mutat Res, 2009.PMID 19622403
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousAnaemia: diagnostic approach — vivahaematology-oncology-and-transfusionNextBleeding child: diagnostic approach: Vivahaematology-oncology-and-transfusion